Metropolis Healthcare Ltd
NSE:METROPOLIS

Watchlist Manager
Metropolis Healthcare Ltd Logo
Metropolis Healthcare Ltd
NSE:METROPOLIS
Watchlist
Price: 2 058.15 INR 1.39% Market Closed
Market Cap: 105.5B INR
Have any thoughts about
Metropolis Healthcare Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one METROPOLIS stock under the Base Case scenario is 2 296.76 INR. Compared to the current market price of 2 058.15 INR, Metropolis Healthcare Ltd is Undervalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

METROPOLIS Relative Value
Base Case
2 296.76 INR
Undervaluation 10%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.2
P/S
P/S
Price to Sales
8.2
vs History
36
vs Industry
16
Median 3Y
7.4
Median 5Y
8.4
Industry
2.3
Forward
7.6
More Details
71.2
P/E
P/E
Price to Earnings
71.2
vs History
9
vs Industry
5
Median 3Y
56.1
Median 5Y
57.5
Industry
23.2
Forward
57.4
More Details
38
P/OCF
P/OCF
Price to OCF
38
vs History
41
vs Industry
9
Median 3Y
35.3
Median 5Y
39.7
Industry
14.3
More Details
108.9
P/FCFE
P/FCFE
Price to FCFE
108.9
vs History
20
vs Industry
2
Median 3Y
49.7
Median 5Y
63.9
Industry
20.1
More Details
8.9
P/B
P/B
Price to Book Value
8.9
vs History
53
vs Industry
7
Median 3Y
8.4
Median 5Y
10
Industry
2.2
More Details
8.1
EV/S
EV/S
Enterprise Value to Sales
8.1
vs History
38
vs Industry
14
Median 3Y
7.4
Median 5Y
8.2
Industry
2.4
Forward
7.5
More Details
10.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.3
vs History
39
vs Industry
19
Median 3Y
9.5
Median 5Y
10.8
Industry
5
More Details
33.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
33.4
vs History
34
vs Industry
7
Median 3Y
30.4
Median 5Y
32.4
Industry
12.8
Forward
29.6
More Details
49.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
49.9
vs History
9
vs Industry
6
Median 3Y
40.7
Median 5Y
43.5
Industry
17.2
Forward
41.9
More Details
37.7
EV/OCF
EV/OCF
Enterprise Value to OCF
37.7
vs History
41
vs Industry
9
Median 3Y
35.3
Median 5Y
39.4
Industry
14
More Details
47.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
47.4
vs History
36
vs Industry
9
Median 3Y
45.2
Median 5Y
49.1
Industry
18.2
More Details
7.8
EV/IC
EV/IC
Enterprise Value to IC
7.8
vs History
50
vs Industry
11
Median 3Y
6.6
Median 5Y
8.6
Industry
1.9
More Details

Multiples Across Competitors

METROPOLIS Competitors Multiples
Metropolis Healthcare Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Metropolis Healthcare Ltd
NSE:METROPOLIS
105.5B INR 8.2 71.2 33.4 49.9
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
Cigna Corp
NYSE:CI
77.9B USD 0.3 25.6 8 10.3
US
CVS Health Corp
NYSE:CVS
56B USD 0.2 11.2 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR 1.3 49 11.2 25.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49.2 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.3 13.2 20.4
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.4 12.3 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 24.5 7.1 16.4
US
DaVita Inc
NYSE:DVA
12.7B USD 1 15.4 8 11.1

See Also

Summary
METROPOLIS intrinsic value, competitors valuation, and company profile.
DCF Valuation
METROPOLIS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
METROPOLIS stock valuation using valuation multiples.
Wall Street Estimates
METROPOLIS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
METROPOLIS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.